These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29335408)

  • 21. T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect.
    Zhou M; Sacirbegovic F; Zhao K; Rosenberger S; Shlomchik WD
    Nat Commun; 2020 Aug; 11(1):4227. PubMed ID: 32839441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rejection of leukemic cells requires antigen-specific T cells with high functional avidity.
    Vincent K; Hardy MP; Trofimov A; Laumont CM; Sriranganadane D; Hadj-Mimoune S; Salem Fourati I; Soudeyns H; Thibault P; Perreault C
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):37-45. PubMed ID: 24161924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of the thymic selection process in transgenic mice expressing SV40 large T antigen.
    Lee WH; Seo JS
    Int J Cancer; 1996 Jul; 67(3):399-404. PubMed ID: 8707415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
    Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide.
    Choi EY; Christianson GJ; Yoshimura Y; Sproule TJ; Jung N; Joyce S; Roopenian DC
    Immunity; 2002 Nov; 17(5):593-603. PubMed ID: 12433366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transduction in thymus development.
    Sen J
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):197-215. PubMed ID: 11292256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dominant role for the thymus and MHC genes in determining the peripheral CD4/CD8 T cell ratio in the rat.
    Damoiseaux JG; Cautain B; Bernard I; Mas M; van Breda Vriesman PJ; Druet P; Fournié G; Saoudi A
    J Immunol; 1999 Sep; 163(6):2983-9. PubMed ID: 10477560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
    Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
    J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The level of CD4 surface protein influences T cell selection in the thymus.
    Frank GD; Parnes JR
    J Immunol; 1998 Jan; 160(2):634-42. PubMed ID: 9551897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation for autoimmune diseases.
    Ikehara S
    Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-amino-acid variant of the H60 CD8 epitope generates specific immunity with diverse TCR recruitment.
    Ryu SJ; Jeon JY; Chang J; Sproule TJ; Roopenian DC; Choi EY
    Mol Cells; 2012 Apr; 33(4):393-9. PubMed ID: 22441676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thymic epithelium in the establishment of transplantation tolerance.
    Coutinho A; Salaün J; Corbel C; Bandeira A; Le Douarin N
    Immunol Rev; 1993 Jun; 133():225-40. PubMed ID: 8225369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.
    Vatakis DN; Koya RC; Nixon CC; Wei L; Kim SG; Avancena P; Bristol G; Baltimore D; Kohn DB; Ribas A; Radu CG; Galic Z; Zack JA
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):E1408-16. PubMed ID: 22123951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8+ T cell tolerance and cancer immunotherapy.
    De Visser KE; Schumacher TN; Kruisbeek AM
    J Immunother; 2003; 26(1):1-11. PubMed ID: 12514424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of CTL Clones Specific for Single Antigen, H60 Minor Histocompatibility Antigen.
    Jeon JY; Jung KM; Chang J; Choi EY
    Immune Netw; 2011 Apr; 11(2):100-6. PubMed ID: 21637387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell technologies are revolutionizing the approach to rare cells.
    Proserpio V; Lönnberg T
    Immunol Cell Biol; 2016 Mar; 94(3):225-9. PubMed ID: 26620630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The escapee.
    Jameson H
    Nature; 2021 Aug; ():. PubMed ID: 34349274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.